Pharmaceutical Technology | Drug Development News & Views …
Pharmaceutical news and in-depth feature articles on the new drug discoveries, healthcare research and development, big pharma trends and company deals.
News - Pharmaceutical Technology
FDA approves Ionis’ TRYNGOLZA for FCS treatment. The US Food and Drug Administration (FDA) has approved Ionis Pharmaceuticals' TRYNGOLZA (olezarsen), designed as an adjunct to diet for…
Reprieve for WuXi as Biosecure vote likely pushed to 2025
Dec 16, 2024 · The Biosecure Act was left out of a key US defence bill that passed in the House last week, in a major win for Chinese CDMOs. Shares in WuXi AppTec (Shanghai, China) opened 10.5% higher on December 9 compared to the previous market close while shares of several Indian CDMOs fell when the news was revealed.
Latest News - Pharmaceutical Technology
6 days ago · Sections. Clinical Trials; Drug Manufacturers; Therapy Area; Pricing and Market Access; Latest. MSD makes obesity play in up to $2bn deal for Hansoh’s GLP-1RA asset
ADCs breach barriers to become mainstream cancer treatment
Dec 17, 2024 · The antibody-drug conjugate (ADC) manufacturing landscape offers the potential to leverage significant opportunities for cancer treatment, but faces complex challenges. Nevertheless, the ADC market potential is significant, with one estimate by CAS, a division of the American Chemical Society ...
Novo gets the green light for once-daily haemophilia drug …
1 day ago · Novo Nordisk has secured approval from the US Food and Drug Administration (FDA) for Alhemo (concizumab-mtci) as a once-daily treatment to prevent or reduce bleeding episodes in adults and children aged 12 years and older with haemophilia A or B with inhibitors.. This approval comes after a tumultuous development history for the drug, including a temporary halt of Phase III trials in 2020 due ...
How technology could transform drug research in 2022
Dec 14, 2021 · When we think of new technologies in medicine, we tend to conjure images of futuristic AI computers, 3D-printed organs, and robot surgeons.The ambitious and lesser-explored methods currently being applied in drug discovery and development, however, could prove to be just as exciting.. A GlobalData survey this year revealed that over 70% of pharma industry respondents anticipate drug ...
Pharmaceutical Technology’s most-read stories of 2023
Dec 19, 2023 · As the year comes to a close, we at Pharmaceutical Technology take stock at some of the biggest headlines of the year. One of the most popular stories on the site was a forward-looking feature that outlined the biggest expected catalysts involving CRISPR gene therapies and posited 2023 as the milestone year for this approach. The interest in this cutting edge technology was unsurprising given ...
Digital transformation expected to shorten drug development …
Nov 27, 2024 · Commenting on the results Urte Jakimaviciute, senior director of market research and strategic intelligence at GlobalData, said: “Survey findings highlight that the growing recognition within the pharmaceutical industry that technology, particularly AI, is accelerating innovation and efficiency in the drug discovery and development process, enabling processes such as faster identification of ...
Cell and gene therapy approvals drive paradigm change in …
Oct 14, 2024 · From early phase to commercialisation, cell and gene therapies introduce a range of unique challenges – from the complexities of running a patient-centric rare disease trial and the importance of extended follow-up periods for monitoring patient safety and efficacy to the significant cost of treatments and the critical need to demonstrate strong value …
- Some results have been removed